content_image/247816.jpg
## Item 15. Exhibits and Financial Statement Schedules 

(a) The following documents are filed as part of this report: 

1. Financial Statements. The following Consolidated Financial Statements of Mineral Technologies Inc. and subsidiary companies and Reports of Independent Registered Public Accounting Firm are set forth on pages F-2 to F-33. 

Consolidated Balance Sheets as of December 31, 2013 and 2012 

Consolidated Statements of Income for the years ended December 31, 2013, 2012 and 2011 

Consolidated Statements of Comprehensive Income for the years ended December 31, 2013, 2012 and 2011 

Consolidated Statements of Cash Flows for the years ended December 31, 2013, 2012 and 2011 

Consolidated Statements of Shareholders' Equity for the years ended December 31, 2013, 2012 and 2011 

Notes to the Consolidated Financial Statements 

Reports of Independent Registered Public Accounting Firm 

Management's Report on Internal Control Over Financial Reporting 

2. Financial Statement Schedule. The following financial statement schedule is filed as part of this report: 

<img src='content_image/247816.jpg'>

All other schedules for which provision is made in the applicable accounting regulations of the SEC are not required under the related instructions or are inapplicable and, therefore, have been omitted. 

3. Exhibits. The following exhibits are filed as part of, or incorporated by reference into, this report. 

3.1 - Restated Certificate of Incorporation of the Company (1) 

3.2 - By-Laws of the Company as amended and restated effective May 25, 2005 (2) 

4.1 - Specimen Certificate of Common Stock (1) 

10.1 - Asset Purchase Agreement, dated as of September 28, 1992, by and between Specialty Refractories Inc. and Quigley Company Inc. (3) 

10.1(a) - Agreement dated October 22, 1992 between Specialty Refractories Inc. and Quigley Company Inc., amending Exhibit 10.1 (4) 

10.1(b) - Letter Agreement dated October 29, 1992 between Specialty Refractories Inc. and Quigley Company Inc., amending Exhibit 10.1 (4) 

10.2 - Reorganization Agreement, dated as of September 28, 1992, by and between the Company and Pfizer Inc (3) 

10.3 - Asset Contribution Agreement, dated as of September 28, 1992, by and between Pfizer Inc and Specialty Minerals Inc. (3) 

10.4 - Asset Contribution Agreement, dated as of September 28, 1992, by and between Pfizer Inc and Barretts Minerals Inc. (3) 

10.4(a) - Agreement dated October 22, 1992 between Pfizer Inc, Barretts Minerals Inc. and Specialty Minerals Inc., amending Exhibits 10.3 and 10.4 (4) 

10.5 - Employment Agreement, dated November 27, 2006, between the Company and Joseph C. Muscari (5) (+) 

10.5(a) - Second Amendment to Employment Agreement, dated July 21, 2010, between the Company and Joseph C. Muscari (6) (+) 

10.5(b) - Third Amendment to Employment Agreement, dated February 21, 2013, by and between Joseph C. Muscari and the Company (7) (+) 

10.6 Employment Agreement, dated February 4, 2013, between the Company and Robert S. Wetherbee (8) (+) 

10.7 - Form of Employment Agreement between the Company and each of Michael A. Cipolla, Douglas T. Dietrich, Jonathan J. Hastings, Douglas W. Mayger, Thomas J. Meek and D.J. Monagle, III (9) (+) 

10.7(a) - Form of amendment to Employment Agreement between the Company and each of Joseph C. Muscari, Michael A. Cipolla, Douglas T. Dietrich, Jonathan J. Hastings, Douglas W. Mayger, Thomas J. Meek, D.J. Monagle III and Johannes C. Schut (10) (+) 

10.8 - Form of Severance Agreement between the Company and each of Joseph C. Muscari, Robert S. Wetherbee, Michael A. Cipolla, Douglas T. Dietrich, Jonathan J. Hastings, Douglas W. Mayger, Thomas J. Meek, D.J. Monagle and Johannes C. Schut (11) (+) 

10.8(a) - Form of amendment to Severance Agreement between the Company and each of Joseph C. Muscari, Robert S. Wetherbee, Michael A. Cipolla, Douglas T. Dietrich, Jonathan J. Hastings, Douglas W. Mayger, Thomas J. Meek and D.J. Monagle, III (12) (+) 

